Cargando…
How the Lack of Chitosan Characterization Precludes Implementation of the Safe-by-Design Concept
Efficacy and safety of nanomedicines based on polymeric (bio)materials will benefit from a rational implementation of a Safe-by-Design (SbD) approach throughout their development. In order to achieve this goal, however, a standardization of preparation and characterization methods and their accurate...
Autores principales: | Marques, Cíntia, Som, Claudia, Schmutz, Mélanie, Borges, Olga, Borchard, Gerrit |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7077258/ https://www.ncbi.nlm.nih.gov/pubmed/32211394 http://dx.doi.org/10.3389/fbioe.2020.00165 |
Ejemplares similares
-
Chitosan Nanoparticles: Shedding Light on Immunotoxicity and Hemocompatibility
por: Jesus, Sandra, et al.
Publicado: (2020) -
Hazard Assessment of Polymeric Nanobiomaterials for Drug Delivery: What Can We Learn From Literature So Far
por: Jesus, Sandra, et al.
Publicado: (2019) -
Editorial: Polymeric Nano-Biomaterials for Medical Applications: Advancements in Developing and Implementation Considering Safety-by-Design Concepts
por: Borchard, Gerrit, et al.
Publicado: (2020) -
A Methodological Safe-by-Design Approach for the Development of Nanomedicines
por: Schmutz, Mélanie, et al.
Publicado: (2020) -
Molecular Modeling for Nanomaterial–Biology Interactions: Opportunities, Challenges, and Perspectives
por: Casalini, Tommaso, et al.
Publicado: (2019)